Literature DB >> 27049897

More data, less information? Potential for nonmonotonic information growth using GEE.

Abigail B Shoben1, Kyle D Rudser2, Scott S Emerson3.   

Abstract

Statistical intuition suggests that increasing the total number of observations available for analysis should increase the precision with which parameters can be estimated. Such monotonic growth of statistical information is of particular importance when data are analyzed sequentially, such as in confirmatory clinical trials. However, monotonic information growth is not always guaranteed, even when using a valid, but inefficient estimator. In this article, we demonstrate the theoretical possibility of nonmonotonic information growth when using generalized estimating equations (GEE) to estimate a slope and provide intuition for why this possibility exists. We use theoretical and simulation-based results to characterize situations that may result in nonmonotonic information growth. Nonmonotonic information growth is most likely to occur when (1) accrual is fast relative to follow-up on each individual, (2) correlation among measurements from the same individual is high, and (3) measurements are becoming more variable further from randomization. In situations that may lead to nonmonotonic information growth, study designers should plan interim analyses to avoid situations most likely to result in nonmonotonic information growth.

Entities:  

Keywords:  Group sequential trials; information growth; longitudinal data

Mesh:

Year:  2016        PMID: 27049897      PMCID: PMC5620018          DOI: 10.1080/10543406.2016.1167071

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  11 in total

1.  Sequential monitoring for comparison of changes in a response variable in clinical studies.

Authors:  M C Wu; K K Lan
Journal:  Biometrics       Date:  1992-09       Impact factor: 2.571

2.  Estimating equations for association structures.

Authors:  Jun Yan; Jason Fine
Journal:  Stat Med       Date:  2004-03-30       Impact factor: 2.373

3.  Flexible implementations of group sequential stopping rules using constrained boundaries.

Authors:  Bart E Burington; Scott S Emerson
Journal:  Biometrics       Date:  2003-12       Impact factor: 2.571

4.  Group sequential clinical trials for longitudinal data with analyses using summary statistics.

Authors:  John M Kittelson; Katrina Sharples; Scott S Emerson
Journal:  Stat Med       Date:  2005-08-30       Impact factor: 2.373

5.  Group sequential clinical trials with triangular continuation regions.

Authors:  J Whitehead; I Stratton
Journal:  Biometrics       Date:  1983-03       Impact factor: 2.571

6.  A multiple testing procedure for clinical trials.

Authors:  P C O'Brien; T R Fleming
Journal:  Biometrics       Date:  1979-09       Impact factor: 2.571

7.  Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy.

Authors:  Wilfred D Stein; James L Gulley; Jeff Schlom; Ravi A Madan; William Dahut; William D Figg; Yang-Min Ning; Phil M Arlen; Doug Price; Susan E Bates; Tito Fojo
Journal:  Clin Cancer Res       Date:  2010-11-24       Impact factor: 12.531

8.  High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

Authors:  Paul S Aisen; Lon S Schneider; Mary Sano; Ramon Diaz-Arrastia; Christopher H van Dyck; Myron F Weiner; Teodoro Bottiglieri; Shelia Jin; Karen T Stokes; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2008-10-15       Impact factor: 56.272

9.  Tolvaptan in patients with autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Arlene B Chapman; Olivier Devuyst; Ron T Gansevoort; Jared J Grantham; Eiji Higashihara; Ronald D Perrone; Holly B Krasa; John Ouyang; Frank S Czerwiec
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

10.  The effect of antiretroviral treatment of different durations in primary HIV infection.

Authors:  Nikos Pantazis; Giota Touloumi; Philippe Vanhems; John Gill; Heiner C Bucher; Kholoud Porter
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.